Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Blass

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Addiction Neuroscience|March 13, 2023
HIV gp120 impairs nucleus accumbens neuroimmune function and dopamine D3 receptor-mediated inhibition of cocaine seeking in male ratsMark D Namba, Megan N Phillips, Peng-Jen Chen, et al.
Journal of Chemical Information and Modeling|February 4, 2021
Targeting SARS-CoV-2 M3CLpro by HCV NS3/4a Inhibitors: <i>In Silico</i> Modeling and <i>In Vitro</i> ScreeningAnjela Manandhar, Benjamin E Blass, Dennis J Colussi, et al.
Frontiers in Behavioral Neuroscience|November 17, 2022
5-HT<sub>1B</sub> receptor agonist enhances breakpoint for cocaine on a progressive ratio (PR) schedule during maintenance of self-administration in female rats but reduces breakpoint for sucroseSamantha N Scott, Brielle A Ruscitti, Raul Garcia, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
Parallel synthesis and evaluation of N-(1-phenylethyl)-5-phenyl-imidazole-2-amines as Na+/K+ ATPase inhibitorsB E Blass, C T Huang, R M Kawamoto, et al.
Experimental Neurology|November 11, 2021
Dopamine D3 receptor ligand suppresses the expression of levodopa-induced dyskinesia in nonhuman primate model of parkinson's diseaseThomas Oh, Elyas S Daadi, Jeffrey Kim, et al.
Journal of Psychopharmacology (Oxford, England)|May 29, 2021
5-HT<sub>1B</sub> receptor agonist attenuates cocaine self-administration after protracted abstinence and relapse in ratsSamantha N Scott, Raul Garcia, Gregory L Powell, et al.
Biomolecules|July 26, 2020
The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley RatsGregory L Powell, Mark D Namba, Annika Vannan, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2006
Discovery and in vitro/in vivo studies of tetrazole derivatives as Kv1.5 blockersShengde Wu, Andrew Fluxe, Jim Sheffer, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2019
Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl)butyl)-4-(thiophen-3-yl)benzamides as selective dopamine D<sub>3</sub> receptor ligandsPeng-Jen Chen, Michelle Taylor, Suzy A Griffin, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 7, 2024
Novel 5-HT<sub>7</sub> receptor antagonists modulate intestinal immune responses and reduce severity of colitisYun Han Kwon, Benjamin E Blass, Huaqing Wang, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Addiction Neuroscience|March 13, 2023
HIV gp120 impairs nucleus accumbens neuroimmune function and dopamine D3 receptor-mediated inhibition of cocaine seeking in male ratsMark D Namba, Megan N Phillips, Peng-Jen Chen, et al.
Journal of Chemical Information and Modeling|February 4, 2021
Targeting SARS-CoV-2 M3CLpro by HCV NS3/4a Inhibitors: <i>In Silico</i> Modeling and <i>In Vitro</i> ScreeningAnjela Manandhar, Benjamin E Blass, Dennis J Colussi, et al.
Frontiers in Behavioral Neuroscience|November 17, 2022
5-HT<sub>1B</sub> receptor agonist enhances breakpoint for cocaine on a progressive ratio (PR) schedule during maintenance of self-administration in female rats but reduces breakpoint for sucroseSamantha N Scott, Brielle A Ruscitti, Raul Garcia, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2000
Parallel synthesis and evaluation of N-(1-phenylethyl)-5-phenyl-imidazole-2-amines as Na+/K+ ATPase inhibitorsB E Blass, C T Huang, R M Kawamoto, et al.
Experimental Neurology|November 11, 2021
Dopamine D3 receptor ligand suppresses the expression of levodopa-induced dyskinesia in nonhuman primate model of parkinson's diseaseThomas Oh, Elyas S Daadi, Jeffrey Kim, et al.
Journal of Psychopharmacology (Oxford, England)|May 29, 2021
5-HT<sub>1B</sub> receptor agonist attenuates cocaine self-administration after protracted abstinence and relapse in ratsSamantha N Scott, Raul Garcia, Gregory L Powell, et al.
Biomolecules|July 26, 2020
The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley RatsGregory L Powell, Mark D Namba, Annika Vannan, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2006
Discovery and in vitro/in vivo studies of tetrazole derivatives as Kv1.5 blockersShengde Wu, Andrew Fluxe, Jim Sheffer, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2019
Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl)butyl)-4-(thiophen-3-yl)benzamides as selective dopamine D<sub>3</sub> receptor ligandsPeng-Jen Chen, Michelle Taylor, Suzy A Griffin, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 7, 2024
Novel 5-HT<sub>7</sub> receptor antagonists modulate intestinal immune responses and reduce severity of colitisYun Han Kwon, Benjamin E Blass, Huaqing Wang, et al.
Pageof 6